Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters

Year range
1.
TMR Integrative Medicine ; 5, 2021.
Article in English | EMBASE | ID: covidwho-1573209

ABSTRACT

Patients with novel coronavirus disease-19 (COVID-19) pneumonia continue to have problems with respiratory function, physical and psychological function, the ability to perform activities of daily living, and social participation after discharge from the hospital. As such, strengthening rehabilitation treatments for discharged patients and relapse prevention after recovery are important aspects of the prevention and control of COVID-19. This paper combined the principles and practices of in Chinese and Western medicine and compiled the recommendations of both for home rehabilitation in the post-COVID-19 epidemic stage. The purpose of this paper is to facilitate the self-rehabilitation of patients with COVID-19 and to promote the prevention and control of COVID-19 at this current stage.

2.
Chinese Traditional and Herbal Drugs ; 52(8):2438-2448, 2021.
Article in Chinese | EMBASE | ID: covidwho-1229449

ABSTRACT

Glycyrrhizae Radix et Rhizoma is a commonly used clinical compatible Chinese herbal medicine, which is listed as one of the highest grade herb in Shengnong's Classic of Materia Medica. Glycyrrhizae Radix et Rhizoma has a variety of chemical constituents, and more than 400 kinds of flavonoids, triterpenoids, coumarins, stilbenoids and other kinds of compounds have been found so far. Modern pharmacological studies have shown that Glycyrrhizae Radix et Rhizoma has a wide range of anti-tumor, anti-inflammatory, antibacterial, antiviral, neuroprotective, liver protective, and other pharmacological effects. Related research progress on newly discovered chemical components, artificially modified chemical constituents, effects of processing on chemical components, and pharmacological effects at home and abroad in recent years are reviewed in this paper, which will provide references for the further development of Glycyrrhizae Radix et Rhizoma.

3.
Non-conventional | WHO COVID | ID: covidwho-46944

ABSTRACT

There are an increasing number of patients suffering from coronavirus disease 2019 (COVID-19) in our country and overseas. After the outbreak, the state health administrative sections have updated steadily several editions of Diagnosis and Treatment of Novel Coronavirus Pneumonia. According to the change of exposition of traditional Chinese medicine (TCM) treatment in these editions and the characteristics of cases in clinic, COVID-19 corresponds to pestilence category of TCM, which also based on the ancient literatures from the seasonal-febrile-disease subject of TCM. The disease contributes to pestilential pathogen caused by specifically regional climate characteristics of Wuhan city. It is important for COVID-19 patients to eliminate pathogens as soon as possible, which should apply defense-qi-nutrient-blood diagnosis to different courses of disease. The TCM therapy should be established according to the different organs where the virus lives and characters. In order to control the epidemic at an early date, it is necessary to consider the local conditions and use the combination of traditional Chinese and western medicine to treat COVID -19 patients.

SELECTION OF CITATIONS
SEARCH DETAIL